Quantitative splenic embolization possible: application of 8Spheres conformal microspheres in partial splenic embolization (PSE)

Background To investigate the safety and efficacy of 8Spheres in partial splenic embolization. To explore the possibility of accurate control of splenic embolic volume by quantifying the number of microspheres used during PSE. Method The data of 179 patients who underwent PSE were collected. The patients were divided into two groups: 300-500 um microsphere group (N = 83) and 500-700 um microsphere group (N = 96). The spleen volume before PSE, infarct volume and infarct rate of the spleen after PSE, changes in peripheral blood cells after PSE, postoperative adverse events and incidence of infection were compared between the two groups. Results 300-500 um group vs 500-700 um group: postoperative spleen volume (cm(3)): 753.82 +/- 325.41 vs 568.65 +/- 298.16 (P = 0.008); spleen embolization volume (cm(3)): 525.93 +/- 118.29 vs 630.26 +/- 109.71 (P = 0.014); spleen embolization rate: 41.1 +/- 12.3% vs 52.4 +/- 10.1% (P = 0.021). Leukocytes and platelets were significantly increased after PSE in both groups; leukocyte, 1 month: 4.13 +/- 0.91 vs 5.08 +/- 1.16 (P = 0.026); 3 months: 4.08 +/- 1.25 vs 4.83 +/- 0.98 (P = 0.022); platelet, 1 month: 125.6 +/- 20.3 vs 138.7 +/- 18.4 (P = 0.019); 3 months: 121.8 +/- 16.9 vs 134.3 +/- 20.1 (P = 0.017). Incidence of abdominal pain after PSE, 72 (86.7%) vs 69 (71.9%), P = 0.027. The incidence of other adverse events and infections after PSE was not statistically different. Conclusion PSE with 8Spheres is safe and effective. The use of 500-700 um microsphere for PSE can make the increase of peripheral blood cells more stable. Each vial of 8Spheres corresponds to a certain volume of splenic embolization, so it is possible to achieve quantitative embolization in PSE.